EU Drug Shortage Prevention Plan Includes Measures For Brexit
Brexit, pediatric formulations and multilingual packages are among the topics addressed in a newly published action plan on improving the availability of medicines authorized in the EU.
You may also be interested in...
A new survey has found that more than 90% of European hospital pharmacies see medicine shortages as an ongoing problem, and that more than a third experience shortages on a weekly basis. In many cases the pharmacists blame manufacturers for failing to notify them of impending shortages.
The European Medicines Agency and the EU Heads of Medicines Agencies network are working together on a broad range of subjects, from big data to the availability of medicines… and of course, Brexit.
Drugs combining codeine and ibuprofen were among the latest products for which the European Medicines Agency has recommended new risk minimization measures –Imbruvica and terlipressin-containing medicines were the others.